What Happened?
Shares of diversified science and technology company Danaher (NYSE: DHR)
fell 13.3% in the morning session after it reported underwhelming second-quarter results. The negative reaction appeared to stem from underlying concerns about the company's profitability.
While revenue grew 5.5% year over year to $6.27 billion and adjusted earnings per share of $1.94 beat estimates, the company's adjusted operating margin contracted significantly to 18%, a steep drop of 9.3 percentage points from the same quarter last year.
This suggests the company's expenses grew much faster than its sales, eroding its efficiency. The margin decline, coupled with a longer-term trend of falling profitability and weak five-year revenue growth, likely overshadowed the quarterly beat and a modest increase in the full-year profit forecast, leaving investors concerned about the company's future performance.
The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Danaher? Access our full analysis report here, it’s free.
What Is The Market Telling Us
Danaher’s shares are not very volatile and have only had 5 moves greater than 5% over the last year. Moves this big are rare for Danaher and indicate this news significantly impacted the market’s perception of the business.
The previous big move we wrote about was 26 days ago when the stock gained 2.8% on the news that its recently acquired subsidiary, Masimo, received U.S. Food and Drug Administration (FDA) clearance for an artificial intelligence-enabled feature on its wearable patient monitoring platform.
The approved feature is designed to detect opioid-induced respiratory depression, a serious medical condition. Danaher officially acquired Masimo in June 2026, a move that expanded its footprint in specialty diagnostics and patient-monitoring technologies. Investors reacted favorably to the regulatory clearance for the new AI-powered system, viewing it as a positive development for the newly integrated business.
Danaher is down 25.1% since the beginning of the year, and at $172.51 per share, it is trading 28.7% below its 52-week high of $242.05 from January 2026. Investors who bought $1,000 worth of Danaher’s shares 5 years ago would now be looking at only $616.53.
WHILE YOU’RE HERE: The Next Palantir? One satellite company captures images of every point on Earth. Every single day. The Pentagon wants it. Hedge funds are using it to beat earnings. You’ve probably never heard of it.
This is what the early days of Palantir looked like before it became a giant. Same playbook. Different technology. If you missed Palantir, you need to see this. Claim The Stock Ticker for Free HERE.
